Evidence map›Paper›PMID 35275754›Full record

ArticleScience immunology2022

Eosinophils are an essential element of a type 2 immune axis that controls thymus regeneration.

Emilie J Cosway, Andrea J White, Sonia M Parnell, Edina Schweighoffer, Helen E Jolin, Andrea Bacon, Hans-Reimer Rodewald, Victor Tybulewicz, Andrew N J McKenzie, William E Jenkinson and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Science immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Tissue adaptation of eosinophils.Journal of leukocyte biology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Emilie J CoswayInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.ORCID 0000-0001-7207-2511
Andrea J WhiteInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Sonia M ParnellInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.ORCID 0000-0002-4430-9072
Edina SchweighofferFrancis Crick Institute, London NW1 1AT, UK.ORCID 0000-0002-9421-6763
Helen E JolinMRC Laboratory of Molecular Biology, Cambridge, UK.
Andrea BaconInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.ORCID 0000-0003-2688-8952
Hans-Reimer RodewaldDivision of Cellular Immunology, German Cancer Research Center, 69120 Heidelberg, Germany.
Victor TybulewiczFrancis Crick Institute, London NW1 1AT, UK.ORCID 0000-0003-2439-0798
Andrew N J McKenzieMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID 0000-0001-9757-2512
William E JenkinsonInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.ORCID 0000-0003-3422-8372
Graham AndersonInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.ORCID 0000-0002-2917-4085
University of Birmingham · GBMRC Laboratory of Molecular Biology · GBThe Francis Crick Institute · GBGerman Cancer Research Center · DE

Funding

Medical Research Council FC001194Medical Research Council MC_U105178805Medical Research Council MR/T029765/1Wellcome Trust FC001194
6 · The paper itself

Abstract

Therapeutic interventions used for cancer treatment provoke thymus damage and limit the recovery of protective immunity. Here, we show that eosinophils are an essential part of an intrathymic type 2 immune network that enables thymus recovery after ablative therapy. Within hours of damage, the thymus undergoes CCR3-dependent colonization by peripheral eosinophils, which reestablishes the epithelial microenvironments that control thymopoiesis. Eosinophil regulation of thymus regeneration occurs via the concerted action of NKT cells that trigger CCL11 production via IL4 receptor signaling in thymic stroma, and ILC2 that represent an intrathymic source of IL5, a cytokine that therapeutically boosts thymus regeneration after damage. Collectively, our findings identify an intrathymic network composed of multiple innate immune cells that restores thymus function during reestablishment of the adaptive immune system.

Indexed as

EosinophilsRegenerationThymus GlandAdaptive ImmunityCytokinesInterleukin-5LymphocytesCytokinesInterleukin-5

Identifiers

PMID35275754
PMCPMC7612579
OpenAlexW4221095104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.